Phase I trial of lenalidomide in combination with plerixafor for relapsed/refractory chronic lymphocytic leukemia (CLL): follow-up and correlative analysis

Published

Conference Paper

Full Text

Duke Authors

Cited Authors

  • Brander, D; Weinberg, JB; Friedman, D; Stewart, T; Rizzieri, D

Published Date

  • December 1, 2017

Published In

Volume / Issue

  • 58 /

Start / End Page

  • 35 - 37

Published By

Pages

  • 3

Electronic International Standard Serial Number (EISSN)

  • 1029-2403

International Standard Serial Number (ISSN)

  • 1042-8194